Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age

Overview of attention for article published in Clinical Ophthalmology, June 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Long-term Outcomes of Myopic Choroidal Neovascularization and Retinal Changes according to ATN Classification

Article in Journal of the Korean Ophthalmological Society (June 2023)

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization

Article in Clinical Ophthalmology (June 2021)

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study

Article in PLOS ONE (January 2020)